GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,191,000 | +9.1% | 196,709 | -0.3% | 0.06% | 0.0% |
| Q3 2019 | $8,424,000 | +4.9% | 197,371 | -1.3% | 0.06% | 0.0% |
| Q2 2019 | $8,032,000 | +1.2% | 200,042 | +5.4% | 0.06% | -4.9% |
| Q1 2019 | $7,934,000 | +18.2% | 189,832 | +8.1% | 0.06% | +1.7% |
| Q4 2018 | $6,713,000 | +2.1% | 175,619 | +7.2% | 0.06% | +9.1% |
| Q3 2018 | $6,578,000 | +3.6% | 163,819 | +0.8% | 0.06% | -6.8% |
| Q2 2018 | $6,349,000 | 0.0% | 162,525 | 0.0% | 0.06% | 0.0% |
| Q1 2018 | $6,349,000 | +12.6% | 162,525 | +2.3% | 0.06% | +9.3% |
| Q4 2017 | $5,639,000 | -15.3% | 158,801 | -3.1% | 0.05% | -25.0% |
| Q3 2017 | $6,659,000 | -8.2% | 163,819 | -2.7% | 0.07% | -15.3% |
| Q2 2017 | $7,257,000 | +3.4% | 168,293 | +1.1% | 0.08% | -4.5% |
| Q1 2017 | $7,016,000 | +6.2% | 166,500 | -2.9% | 0.09% | -3.3% |
| Q4 2016 | $6,609,000 | -18.2% | 171,454 | -8.5% | 0.09% | -24.0% |
| Q3 2016 | $8,081,000 | -1.4% | 187,378 | -1.0% | 0.12% | -7.6% |
| Q2 2016 | $8,196,000 | +11.1% | 189,206 | +3.9% | 0.13% | +0.8% |
| Q1 2016 | $7,379,000 | +28.2% | 182,124 | +27.8% | 0.13% | +22.6% |
| Q4 2015 | $5,754,000 | +0.6% | 142,526 | -4.5% | 0.11% | -10.2% |
| Q3 2015 | $5,722,000 | -7.1% | 149,183 | +1.0% | 0.12% | +3.5% |
| Q2 2015 | $6,156,000 | -11.5% | 147,771 | -1.9% | 0.11% | -14.3% |
| Q1 2015 | $6,959,000 | +17.8% | 150,705 | +9.2% | 0.13% | +1.5% |
| Q4 2014 | $5,908,000 | +63.2% | 138,059 | +75.3% | 0.13% | +32.3% |
| Q3 2014 | $3,621,000 | -4.1% | 78,755 | +11.5% | 0.10% | -3.9% |
| Q2 2014 | $3,777,000 | -1.8% | 70,628 | -1.9% | 0.10% | -8.0% |
| Q1 2014 | $3,847,000 | +3.5% | 71,994 | +3.4% | 0.11% | -2.6% |
| Q4 2013 | $3,716,000 | +9.5% | 69,594 | +2.9% | 0.12% | 0.0% |
| Q3 2013 | $3,393,000 | -5.1% | 67,622 | -5.5% | 0.12% | -10.2% |
| Q2 2013 | $3,577,000 | – | 71,566 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |